ARCHIVES

Statistical Models Determine Stem-Cell Transplant Effectiveness

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

NCI To Place 20% Cap On Grant Renewal Increases.

May 25, 2001

Femara Better Suppressor Of Estrogen, Study Finds

February 22, 2002

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

January 20, 2006

NCI Plans For Research In Breast, Prostate Cancer, Drafted

January 28, 1994

In Brief: Money Bill Delay Seen Until After Election ACCC Meeting Planned On Community Programs

September 15, 1978

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009